Skip to main content
Table of Contents
Print

Are there clinical trials investigating cannabis for migraine treatment? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Interest in clinical trials on cannabis for migraines  is steadily increasing, driven by patient demand and early evidence suggesting therapeutic potential. While cannabis has been used anecdotally for headache relief, scientific validation through structured trials remains essential for widespread clinical use. 

Several clinical trials on cannabis for migraines have either been completed or are currently underway. These aim to better understand the safety, dosing, and effectiveness of cannabis in managing migraine symptoms. Despite slow progress due to regulatory hurdles, the body of migraine and cannabis studies is growing. 

    Current Focus Areas in Research 

    Here are some of the key areas being explored in cannabis for migraine trials around the world. 

    Dose and formulation testing 

    Researchers are investigating how different THC and CBD ratios affect migraine relief. The goal is to identify the most effective and well-tolerated blends. 

    Comparison with standard treatments 

    Some studies are directly comparing cannabis to traditional migraine medications, contributing to a more robust cannabis treatment clinical research landscape. 

    Inhaled vs oral delivery 

    Trials are examining whether vaping, oils, or capsules deliver better and more consistent results in managing migraine symptoms. 

    Preventive vs acute treatment 

    Ongoing research is trying to determine whether cannabis works better as a preventive therapy or for treating migraines once they begin. 

    As clinical trials on cannabis for migraines continue, they offer valuable insights that will shape future care. With more data, the potential role of cannabis in migraine treatment may move from anecdotal support to medically approved application. 

    If you’re exploring cannabis treatment options for migraines, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

    For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and migraines. 

    Julia Sutton, MSc
    Author

    Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

    All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

    Dr. Clarissa Morton, PharmD
    Reviewer

    Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

    All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

    Categories